DURSUN, E. Et Al. 2024. Dual FES/FDG PET/CT imaging to predict therapy response in patients with estrogen receptor-positive recurrent or metastatic breast cancer: Preliminary Results. Annuals Congress of the European Association of Nuclear Medicine , 493-494.

DURSUN, E., ÖZKAN, E., YAŞAR, H. A., ARAZ, M., AKSOY, S., ÜRÜN, Y., ... KÜÇÜK, N. Ö.(2024). Dual FES/FDG PET/CT imaging to predict therapy response in patients with estrogen receptor-positive recurrent or metastatic breast cancer: Preliminary Results . Annuals Congress of the European Association of Nuclear Medicine (pp.493-494).

DURSUN, ECENUR Et Al. "Dual FES/FDG PET/CT imaging to predict therapy response in patients with estrogen receptor-positive recurrent or metastatic breast cancer: Preliminary Results," Annuals Congress of the European Association of Nuclear Medicine, 2024

DURSUN, ECENUR Et Al. "Dual FES/FDG PET/CT imaging to predict therapy response in patients with estrogen receptor-positive recurrent or metastatic breast cancer: Preliminary Results." Annuals Congress of the European Association of Nuclear Medicine , pp.493-494, 2024

DURSUN, E. Et Al. (2024) . "Dual FES/FDG PET/CT imaging to predict therapy response in patients with estrogen receptor-positive recurrent or metastatic breast cancer: Preliminary Results." Annuals Congress of the European Association of Nuclear Medicine , pp.493-494.

@conferencepaper{conferencepaper, author={ECENUR DURSUN Et Al. }, title={Dual FES/FDG PET/CT imaging to predict therapy response in patients with estrogen receptor-positive recurrent or metastatic breast cancer: Preliminary Results}, congress name={Annuals Congress of the European Association of Nuclear Medicine}, city={}, country={}, year={2024}, pages={493-494} }